Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106127

Measurement of thrombopoiesis in rabbits using 75selenomethionine

Bruce L. Evatt and Jack Levin

1Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland 21205

Find articles by Evatt, B. in: PubMed | Google Scholar

1Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland 21205

Find articles by Levin, J. in: PubMed | Google Scholar

Published September 1, 1969 - More info

Published in Volume 48, Issue 9 on September 1, 1969
J Clin Invest. 1969;48(9):1615–1626. https://doi.org/10.1172/JCI106127.
© 1969 The American Society for Clinical Investigation
Published September 1, 1969 - Version history
View PDF
Abstract

Incorporation of 75selenomethionine (75SeM) has been used to study platelet production in rabbits. Radioactivity of platelets was low after the intravenous administration of 75SeM and rose to a maximum approximately 3 days after administration. Platelet radioactivity was independent of concurrent plasma levels. The life span of rabbit platelets, as estimated with this technique, was 4-5 days. In vivo reutilization of 75SeM previously incorporated into plasma proteins was not detected. In vitro incorporation of 75SeM by platelets in platelet-rich plasma was not demonstrated.

Acute hemorrhage 24 hr before administration of 75SeM increased the incorporation of 75SeM into platelets. Transfusion-induced thrombocytosis reduced the incorporation of 75SeM to approximately 30% of that observed in control animals. Suppression of bone marrow function with nitrogen mustard resulted in decreased numbers of platelets in the circulation, and a decrease in incorporation of 75SeM. Delayed appearance of 75SeM was observed in circulating platelets during recovery from marrow suppression. Injection of 75-225 ml of plasma from thrombocytopenic donors into normal rabbits increased incorporation of 75SeM into platelets while normal plasma did not have this effect.

The rate of appearance of 75SeM in circulating platelets appears to provide a sensitive and specific method for the study of production of platelets by megakaryocytes. The data suggest more rapid entry of platelets into the circulation, and a sustained increase in incorporation of 75SeM into platelet protein after stimulation of platelet production. The results are consistent with the concept of a humoral agent (thrombopoietin) that acts on megakaryocytes to regulate platelet production.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1615
page 1615
icon of scanned page 1616
page 1616
icon of scanned page 1617
page 1617
icon of scanned page 1618
page 1618
icon of scanned page 1619
page 1619
icon of scanned page 1620
page 1620
icon of scanned page 1621
page 1621
icon of scanned page 1622
page 1622
icon of scanned page 1623
page 1623
icon of scanned page 1624
page 1624
icon of scanned page 1625
page 1625
icon of scanned page 1626
page 1626
Version history
  • Version 1 (September 1, 1969): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts